Spire Healthcare Group PLC (SPI.L) stock: key figures, P/E, revenue and dividend

Health Care · United Kingdom · ISIN GB00BNLPYF73

Price
2.49 GBP
Market cap
1.01 bn GBP
P/E (2025)
61.41
P/S (2025)
0.64
Dividend yield
0.60 %
Net margin
1.04 %
Return on equity (ROE)
2.21 %
Return on assets (ROA)
0.69 %

Spire Healthcare Group PLC financials

Fiscal year20242025
Revenue1.51 bn GBP1.58 bn GBP
Gross profit683.00 m GBP599.10 m GBP
Operating income–146.10 m GBP
EBIT141.00 m GBP–
Net income25.00 m GBP16.40 m GBP
Diluted EPS – continuing operations0.06 GBP0.04 GBP

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Spire Healthcare Group PLC

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.